View in EDS

Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.

Saved in:
Bibliographic Details
Title: Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.
Authors: Ramaekers JG; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands. j.ramaekers@maastrichtuniversity.nl., Reckweg JT; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., Mason NL; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., Kuypers KPC; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands., Toennes SW; Goethe University, Institute of Legal Medicine, Frankfurt, Germany., Theunissen EL; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2025 Jun; Vol. 50 (7), pp. 1084-1092. Date of Electronic Publication: 2024 Dec 24.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-634X (Electronic) Linking ISSN: 0893133X NLM ISO Abbreviation: Neuropsychopharmacology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39719487
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ramaekers+JG%22">Ramaekers JG</searchLink>; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands. j.ramaekers@maastrichtuniversity.nl.<br /><searchLink fieldCode="AU" term="%22Reckweg+JT%22">Reckweg JT</searchLink>; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mason+NL%22">Mason NL</searchLink>; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuypers+KPC%22">Kuypers KPC</searchLink>; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Toennes+SW%22">Toennes SW</searchLink>; Goethe University, Institute of Legal Medicine, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Theunissen+EL%22">Theunissen EL</searchLink>; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228904907%22">Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</searchLink> [Neuropsychopharmacology] 2025 Jun; Vol. 50 (7), pp. 1084-1092. <i>Date of Electronic Publication: </i>2024 Dec 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8904907 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1740-634X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220893133X%22">0893133X </searchLink><i>NLM ISO Abbreviation: </i>Neuropsychopharmacology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39719487
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41386-024-02042-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1084
    Titles:
      – TitleFull: Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ramaekers JG
      – PersonEntity:
          Name:
            NameFull: Reckweg JT
      – PersonEntity:
          Name:
            NameFull: Mason NL
      – PersonEntity:
          Name:
            NameFull: Kuypers KPC
      – PersonEntity:
          Name:
            NameFull: Toennes SW
      – PersonEntity:
          Name:
            NameFull: Theunissen EL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1740-634X
          Numbering:
            – Type: volume
              Value: 50
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
              Type: main
ResultId 1